GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $871,000 | 0.0% | 20,000 | 0.0% | 1.26% | +39.0% |
Q1 2022 | $871,000 | -1.2% | 20,000 | 0.0% | 0.91% | +12.5% |
Q4 2021 | $882,000 | +15.4% | 20,000 | 0.0% | 0.81% | +19.0% |
Q3 2021 | $764,000 | -4.0% | 20,000 | 0.0% | 0.68% | +1.8% |
Q2 2021 | $796,000 | +11.5% | 20,000 | 0.0% | 0.67% | +6.4% |
Q1 2021 | $714,000 | +2.1% | 20,000 | +5.3% | 0.63% | +1.8% |
Q4 2020 | $699,000 | +16.1% | 19,000 | +18.8% | 0.62% | -5.8% |
Q3 2020 | $602,000 | -1.6% | 16,000 | +6.7% | 0.66% | -5.3% |
Q2 2020 | $612,000 | +7.7% | 15,000 | 0.0% | 0.69% | -9.5% |
Q1 2020 | $568,000 | -19.4% | 15,000 | 0.0% | 0.76% | +1.7% |
Q4 2019 | $705,000 | +3.2% | 15,000 | -6.2% | 0.75% | -11.7% |
Q3 2019 | $683,000 | +6.7% | 16,000 | 0.0% | 0.85% | +23.1% |
Q2 2019 | $640,000 | -4.3% | 16,000 | 0.0% | 0.69% | +4.5% |
Q1 2019 | $669,000 | +9.5% | 16,000 | 0.0% | 0.66% | -13.6% |
Q4 2018 | $611,000 | -5.0% | 16,000 | 0.0% | 0.77% | +12.2% |
Q3 2018 | $643,000 | -0.3% | 16,000 | 0.0% | 0.68% | +4.8% |
Q2 2018 | $645,000 | +3.2% | 16,000 | 0.0% | 0.65% | -13.2% |
Q1 2018 | $625,000 | -11.8% | 16,000 | -20.0% | 0.75% | -15.8% |
Q4 2017 | $709,000 | +16.4% | 20,000 | +33.3% | 0.89% | +39.6% |
Q3 2017 | $609,000 | -64.7% | 15,000 | -62.5% | 0.64% | -63.1% |
Q2 2017 | $1,725,000 | -25.6% | 40,000 | -27.3% | 1.73% | -26.2% |
Q1 2017 | $2,319,000 | +20.4% | 55,000 | +10.0% | 2.34% | +7.7% |
Q4 2016 | $1,926,000 | +11.7% | 50,000 | +25.0% | 2.18% | +17.3% |
Q3 2016 | $1,725,000 | -0.5% | 40,000 | 0.0% | 1.86% | -6.5% |
Q2 2016 | $1,734,000 | +6.9% | 40,000 | 0.0% | 1.98% | +9.1% |
Q1 2016 | $1,622,000 | -26.9% | 40,000 | -27.3% | 1.82% | -27.5% |
Q4 2015 | $2,219,000 | +4.9% | 55,000 | 0.0% | 2.51% | +3.5% |
Q3 2015 | $2,115,000 | +8.0% | 55,000 | +17.0% | 2.42% | +22.8% |
Q2 2015 | $1,958,000 | -5.7% | 47,000 | +4.4% | 1.98% | -3.7% |
Q1 2015 | $2,077,000 | +247.3% | 45,000 | +221.4% | 2.05% | +224.5% |
Q4 2014 | $598,000 | -7.1% | 14,000 | 0.0% | 0.63% | +4.8% |
Q3 2014 | $644,000 | -4.5% | 14,000 | +11.1% | 0.60% | -10.7% |
Q2 2014 | $674,000 | +0.1% | 12,600 | 0.0% | 0.68% | +1.8% |
Q1 2014 | $673,000 | 0.0% | 12,600 | 0.0% | 0.66% | +11.1% |
Q4 2013 | $673,000 | +11.8% | 12,600 | +5.0% | 0.60% | +17.3% |
Q3 2013 | $602,000 | -76.8% | 12,000 | -76.9% | 0.51% | -76.9% |
Q2 2013 | $2,598,000 | – | 52,000 | – | 2.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |